Adobe

STAT+ | FDA approves Replimune melanoma drug previously rejected twice

Twice-rejected drug cleared an advisory committee last week. Full approval will depend on an ongoing Phase 3 trial with results expected in 2027.

By Elaine Chen

Senate committee votes along party lines to hold Fauci in contempt of Congress

Anthony Fauci invoked Fifth Amendment at hearing he said was designed to entrap him. Committee led by Sen. Rand Paul (R-Ky.), votes to seek contempt charge.

By Daniel Payne

FDA approves Moderna’s mRNA flu vaccine, the first to use the technology

Moderna's mFlusiva to be first mRNA-based flu shot on the market. Approval caps remarkable turn of fortune for technology long targeted by vaccine skeptics.

By Helen Branswell

NIAID/NIH/Science Photo Library

STAT+ | Study reveals new role for tau, a top target for Alzheimer’s drug development

Study reveals closer look at the role of tau plays in neurodegeneration and suggest novel way researchers might block protein’s activity.

By Jonathan Wosen

Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was

In 2025, RFK Jr. claimed data did not support research into mRNA vaccines. The past year shows he was wrong

By Jeff Coller

Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response

Instead of finding a scapegoat or specifically punishing Anthony Fauci, expert calls for 9/11 style commission focused on improved pandemic response.

By Ronald Nahass

Photo illustration: STAT; photo: Courtesy LifeMine Therapeutics

STAT+ | A scientist-turned-biotech executive is notching some wins, and enjoying it

The Harvard University researcher has seen a lot of planted seeds bearing fruit at companies Revolution Medicine, Parabilis, and LifeMine.

By Allison DeAngelis

Opinion: What my colleagues and I will look for as we assess U.S. measles elimination status

Measles cases are way up. There have been 34 outbreaks this year alone. What does this mean for elimination status?

By Noel T. Brewer